Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.
about
Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockersEffects of sertraline on the pharmacokinetics of bupropion and its major metabolite, hydroxybupropion, in mice.The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.Fast-scan cyclic voltammetry analysis of dynamic serotonin reponses to acute escitalopram.Prenatal exposure to escitalopram and/or stress in rats: a prenatal stress model of maternal depression and its treatmentPrediction of exposure-response relationships to support first-in-human study design.Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats.Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.Antidepressant response to chronic citalopram treatment in eight inbred mouse strains.
P2860
Q33764320-289047CF-48CC-4A23-A37A-78D09D218AFEQ34217306-E5866BA7-6989-4ECB-92B1-C0A73AE484DCQ35137131-96F1FB9E-4097-4CDA-A247-30508C2881CCQ35892630-821EFB26-1A45-44CA-85D6-198E90084D94Q36603189-C557F395-C144-42D3-B62F-74C977248B20Q36851651-059FB12F-FC2A-4C57-9907-74B16C595FF2Q37657543-563643A2-9213-43CB-B3E3-015947FDA731Q37802266-5C465E0A-31B0-445A-B5A5-0E6CC59D9726Q37928965-1B37089D-758E-47F6-A90F-98789A9E486FQ38204833-416E7C3D-3FDE-4F27-BC6D-90C4F92D6ED0Q38652284-60832DB3-97F6-4988-A847-1E787327143DQ41940746-9EA73FB8-1F1C-498B-8DA8-7712EFB8CED7Q47869087-810920BF-9E5E-48DE-8841-ECFCA56ED470Q48943165-0812EEC3-C02D-45FF-9630-F5CDF4F39E09
P2860
Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Prediction of clinical respons ...... e reuptake inhibitors in mice.
@en
Prediction of clinical respons ...... e reuptake inhibitors in mice.
@nl
type
label
Prediction of clinical respons ...... e reuptake inhibitors in mice.
@en
Prediction of clinical respons ...... e reuptake inhibitors in mice.
@nl
prefLabel
Prediction of clinical respons ...... e reuptake inhibitors in mice.
@en
Prediction of clinical respons ...... e reuptake inhibitors in mice.
@nl
P2093
P2860
P356
P1476
Prediction of clinical respons ...... e reuptake inhibitors in mice.
@en
P2093
L T Brennum
M Kreilgaard
P2860
P304
P356
10.1038/BJP.2008.243
P407
P577
2008-06-16T00:00:00Z